Neuropathological, biochemical and genetic alterations in AD

Drug News and Perspectives

Volumn 13, Issue 5, 2000, Pages 281-288

  St George Hyslop, P H ^a   McLaurin, J ^a   Fraser, P E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; ENZYME INHIBITOR; GAMMA SECRETASE; SECRETASE INHIBITOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; GENETIC SUSCEPTIBILITY; HUMAN; NEUROTOXICITY; PATHOGENESIS; PROTEIN SYNTHESIS; REVIEW;

EID: 0033797062     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Structural basis of the cognitive alterations in Alzheimer disease
2. The epidemiology of dementia and Alzheimer disease
3. Amyloid β protein and the basis for Alzheimer disease
4. The precursor of Alzheimer disease amyloid A4 protein resembles a cell surface receptor
5. Normal and abnormal biology of B-amyloid precursor protein
6. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
7. Distinct sites of intracellular production for Alzheimer's disease AB40/42-amyloid peptides
8. Discrepancy between Alzheimer type neuropathology and dementia in person with Downs syndrome
9. Onset of dementia is associated with apolipoprotein E e4 in Down syndrome
10. The genetic defect causing familial Alzheimer disease maps on chromosome 21
11. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of B-amyloid
12. Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the B-amyloid precursor protein gene
13. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage - Dutch type
14. Unusual phenotypic alteration of beta amyloid precursor protein maturation by a new Val715Met betaAPP770 mutation for probable early-onset Alzheimer's disease
15. The betaA4 amyloid peptide complexes to and enhances the uptake of beta-very low density lipoproteins by the low density, lipoprotein receptor-related protein and heparin sulfate proteoglycans pathway
16. Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis
17. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation
18. Seeding one-dimensional crystallization of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
19. An important role of heparan sulfate proteoglycan in a model system for the deposition and persistence of fibrillary Ab-amyloid in rat brain
20. Interactions of Alzheimer beta-peptides with glycosaminoglycans: Effects on fibril nucleation and growth
21. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer disease
22. Mechanisms of neuronal degeneration in Alzheimer's disease
23. Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer disease
24. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity
25. Comparison of neurodegenerative pathology in transgenic mice overexpressing v717f beta-amyloid precursor protein and Alzheimer disease
26. Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease
27. Familial Alzheimer's disease in kindreds with missense mutations in a novel gene on chromosome 1 related to the Alzheimer's disease type 3 gene
28. Mutant presenilins of Alzheimer's disease increase production of 42 residue amyloid B-protein in both transfected cells and transgenic mice
29. Deficiency of presenilin 1 inhibits the normal cleavage of amyloid precursor protein
30. Two transmembrane aspartates in presenilin 1 required for presenilin endoproteolysis and gamma-secretase activity
31. Association of apoliprotein E allele e4 with the late-onset familial and sporadic Alzheimer disease
32. Apolipoprotein E and Alzheimer disease: Ethnic variation in genotype risks
33. Increased vascular and plaque beta-A4 amyloid deposits in sporadic Alzheimer disease patients with apolipoprotein e4
34. Alzheimer's disease and possible gene interaction
35. Tau is a candidate gene for chromosome 17 frontotemporal dementia
36. Cell surface presenilin 1 participates in the gamma-secretase-like proteolysis of Notch
37. Beta-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red
38. Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans
39. Synthesis and amyloid binding properties of rhenium complexes: Preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain
40. Controlling polymerization of beta-amyloid and prion-derived peptides with synthetic small molecule ligands
41. Controlling amyloid beta-peptide fibril formation with protease-stable ligands
42. Beta-Sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy
43. Immunization with Abeta attenuates Alzheimer's disease-like pathology in the PDAPP mouse
44. Alzheimer's disease: Antibody clears senile plaques